Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07463911) titled 'Treatment Response In ECT Patients' on March 2.

Study Type: Observational

Primary Sponsor: Nurdan Sagbas

Condition: Major Depression Bipolar Affective Disorder Bipolar Depression Depressed Phase

Intervention: Device: Electroconvulsive Therapy (ECT)

Recruitment Status: Not recruiting

Date of First Enrollment: May 20, 2025

Target Sample Size: 65

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07463911

Published by HT Digital Content Services with permission from Health Daily Digest....